92 related articles for article (PubMed ID: 15202848)
1. Black lunula caused by Tegafur.
Chen GY; Chao SC; Chen W
Acta Derm Venereol; 2004; 84(3):238-9. PubMed ID: 15202848
[No Abstract] [Full Text] [Related]
2. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur.
Rios-Buceta L; Buezo GF; Peñas PF; Dauden E; Fernandez-Herrera J; Garcia-Diez A
Acta Derm Venereol; 1997 Jan; 77(1):80-1. PubMed ID: 9059693
[No Abstract] [Full Text] [Related]
3. Chemotherapy-induced acral erythema due to Tegafur.
Bastida J; Díaz-Cascajo C; Borghi S
Acta Derm Venereol; 1997 Jan; 77(1):72-3. PubMed ID: 9059686
[No Abstract] [Full Text] [Related]
4. Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial.
Yeh YS; Tsai HL; Huang CW; Wei PL; Sung YC; Tang HC; Wang JY
Trials; 2017 Apr; 18(1):191. PubMed ID: 28441966
[TBL] [Abstract][Full Text] [Related]
5. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer.
Kim DJ; Kim TI; Suh JH; Cho YS; Shin SK; Kang JK; Kim NK; Kim WH
Yonsei Med J; 2003 Aug; 44(4):665-75. PubMed ID: 12950123
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase II study of S-1 dosing schedule for resected colorectal cancer.
Matsuda C; Uemura M; Nakata K; Shingai T; Nishimura J; Hata T; Ikenaga M; Takemasa I; Mizushima T; Kato T; Ikeda M; Ohue M; Murata K; Hasegawa J; Satoh T; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
BMC Cancer; 2015 Jun; 15():452. PubMed ID: 26036466
[TBL] [Abstract][Full Text] [Related]
7. Chronic liver failure induced by long-term administration of tegafur: a case report.
Matsumoto M; Nakao K; Matsumoto H; Iwata K; Ohta Y; Kanai K; Takahashi K; Akima M
Hepatogastroenterology; 1998; 45(24):2372-5. PubMed ID: 9951926
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous side-effects caused by Tegafur.
Revenga F
Int J Dermatol; 1999 Dec; 38(12):955-7. PubMed ID: 10671104
[No Abstract] [Full Text] [Related]
9. [The current status of adjuvant chemotherapy of colonic cancer].
Takiuchi H
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1826-8. PubMed ID: 19999632
[No Abstract] [Full Text] [Related]
10. Tegafur-induced hyperpigmentation of the tongue.
Kim HS; Park YM; Kim HO; Lee JY
J Dermatol; 2010 Oct; 37(10):937-8. PubMed ID: 20860752
[No Abstract] [Full Text] [Related]
11. [Capsule instead of infusion--new oral chemotherapy option].
Köhne CH
Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
[No Abstract] [Full Text] [Related]
12. A case of dermatomyositis triggered by tegafur.
Akiyama C; Osada A; Sou K; Yasaka N; Ohtake N; Furue M; Tamaki K
Acta Derm Venereol; 1997 Nov; 77(6):490. PubMed ID: 9394998
[No Abstract] [Full Text] [Related]
13. [The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
Narita T; Seshimo A; Itabashi M; Aratake K; Ogawa S; Hirosawa T; Hashimoto T; Amano K; Kameoka S
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1821-4. PubMed ID: 22083190
[TBL] [Abstract][Full Text] [Related]
14. [Tegafur--preoperative treatment with tegafur suppositories for rectal cancer].
Ohwada S; Sato Y; Yoshimura S; Kawate S; Morishita Y; Kashiwabara K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():341-4. PubMed ID: 14574908
[No Abstract] [Full Text] [Related]
15. Myelodysplastic syndrome/acute myelogenous leukaemia related to adjuvant chemotherapy with oral pyrimidine anti-metabolites.
Abe M; Tanaka Y; Shinohara M; Kosaka M; Matsumoto T
Br J Haematol; 2000 Nov; 111(2):712-3. PubMed ID: 11122127
[No Abstract] [Full Text] [Related]
16. Lethal leukoencephalopathy secondary to Tegafur, a 5-fluorouracil prodrug.
Sierra S; Luquin N; Carrato C
J Neurol Sci; 2015 Oct; 357(1-2):326-8. PubMed ID: 26242718
[No Abstract] [Full Text] [Related]
17. Knuckle pad-like keratoderma: a new cutaneous side reaction induced by tegafur.
Won YH; Seo JJ; Kim SJ; Lee SC; Chun IK
Int J Dermatol; 1998 Apr; 37(4):315-7. PubMed ID: 9585908
[No Abstract] [Full Text] [Related]
18. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT).
Yoshimasu T; Hiroi A; Uede K; Furukawa F
Eur J Dermatol; 2001; 11(1):54-7. PubMed ID: 11174141
[TBL] [Abstract][Full Text] [Related]
19. [Skin and ungual pigmentation caused by ftorafur].
Del Pozo LJ; Vilella J; Jimeno M; Del Villar V; Asensio M
Med Cutan Ibero Lat Am; 1990; 18(1):78-80. PubMed ID: 2214933
[TBL] [Abstract][Full Text] [Related]
20. Standard-dose tegafur combined with uracil is not safe treatment after severe toxicity from 5-fluorouracil or capecitabine.
Deenen MJ; Terpstra WE; Cats A; Boot H; Schellens JH
Ann Intern Med; 2010 Dec; 153(11):767-8. PubMed ID: 21135311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
